[Results of medical treatment in chronic open angle glaucoma].
D000368:Aged; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D004837:Epinephrine / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008916:Miotics / Q000627:therapeutic use*; D009184:Mydriatics / Q000627:therapeutic use*; D010830:Physostigmine / Q000627:therapeutic use*; D010862:Pilocarpine / Q000627:therapeutic use*; D011379:Prognosis; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002257:Carbonic Anhydrase Inhibitors; D006993:Hypnotics and Sedatives; D008916:Miotics; D009184:Mydriatics; D014665:Vasodilator Agents; D010862:Pilocarpine; D010830:Physostigmine; D004837:Epinephrine
Résultats du traitement médical dans le glaucome chronique à angle ouvert.